Exactech Inc. (EXAC)
-NasdaqGS 19.22 
0.64(3.22%) 12:00PM EDT - Nasdaq Real Time Price
| Prev Close: | 19.86 |
|---|
| Open: | 19.80 |
|---|
| Bid: | 19.22 x 300 |
|---|
| Ask: | 19.30 x 100 |
|---|
| 1y Target Est: | 23.00 |
|---|
| Beta: | 0.88 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 19.22 - 19.80 |
|---|
| 52wk Range: | 15.01 - 21.16 |
|---|
| Volume: | 6,205 |
|---|
| Avg Vol (3m): | 23,197 |
|---|
| Market Cap: | 257.95M |
|---|
| P/E (ttm): | 19.20 |
|---|
| EPS (ttm): | 1.00 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Exactech Introduces Conservative Treatment Hip Replacement SystemBusiness Wire(Tue, Jun 11)
- Is Exactech Earning Enough for You?at Motley Fool(Fri, May 31)
- EXACTECH INC FinancialsEDGAR Online Financials(Fri, May 10)
- EXACTECH INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Tue, May 7)
- Exactech Launches Gibralt® OCT Spinal System for Complex Cervical Thoracic Spine Procedures Now Offering Spinal Fusion Solutions For The Entire SpineBusiness Wire(Mon, May 6)
- EXACTECH INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Sun, May 5)
- Covidien's 2Q Earnings BeatZacks(Fri, Apr 26)
- Zimmer Beats Earnings, Misses RevenueZacks(Thu, Apr 25)
- Exactech's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, Apr 24)
- Edwards Lags on Earnings & RevZacks(Wed, Apr 24)
- Annual Report with 10K for Exactech Inc.WILink(Tue, Apr 23)
- Exactech Q1 Net Income up 17% to $3.8 Million; Diluted EPS $.29 vs. $.25; Worldwide Sales Up 1% to $59.3 Million; U.S. Sales Increased 6%Business Wire(Tue, Apr 23)
- EXACTECH INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Tue, Apr 23)
- Q1 2013 Exactech Earnings Release - After Market CloseCCBN(Tue, Apr 23)
- New Product from Abbott LabsZacks(Mon, Apr 22)
Key Statistics
| Forward P/E (1 yr): | 15.38 |
|---|
| P/S (ttm): | 1.18 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.06 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.25 |
|---|
| Mean Recommendation*: | 1.6 |
|---|
| PEG Ratio (5 yr expected): | 1.29 |
|---|
Business Summary
Exactech, Inc. develops, manufactures, markets, and distributes orthopedic implant devices; and related surgical instrumentation, supplies, and biologic materials to hospitals and physicians in the United States and internationally.
View More